Most Recent
Mylan wants injunctions against Sun Pharma, Cipla over generic cholesterol drug
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
Former NAB chief of staff charged over $40M fraud
The former chief of staff to ex-NAB boss Andrew Thorburn has been arrested and charged for her alleged role in a $40 million fraud against the bank.
AFT agrees to temporary injunction over new Maxigesic ads
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.
High profile barrister steps aside in Gayle defamation appeal
Leading defamation barrister Bruce McClintock, SC, has stepped down from representing cricketer Chris Gayle as an appeal by three media organisations against a $326,000 payout gets locked in for a June hearing.
Westpac wants court to raise the bar for ‘personal advice’ finding
Westpac has followed ASIC's lead, launching a separate appeal to a ruling that it provided financial advice but not personal advice as part of a campaign encouraging customers to roll over external superannuation accounts.
Boehringer hits Teva with counterpunch in inhaler patent battle
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.
Google, US groups slam ACCC’s digital platforms report
Google has criticised the ACCC's proposals for stricter oversight of digital platforms, saying the regulator has not identified any problems that couldn't be addressed with its current powers, a concern echoed by US-based competition and industry groups, which warned the proposals could harm competition.
Common fund rulings a boon for class action litigation funders, experts say
Two rulings Friday keeping alive the common fund order are a ringing endorsement by the courts of the important role that litigation funders play in class actions, experts say, and have paved the way for more funded post-Hayne consumer litigation against banks and other financial services firms this year.
Piper Alderman heads to mediation in dispute with female partner accused of bullying
A senior female partner at Piper Alderman will go into mediation this week with representatives of the firm's partnership to try to resolve her sex discrimination lawsuit, which alleges a group of equity partners have used baseless complaints of bullying to try to push her out.
Judges have the power to issue common fund orders, appeals courts rule
Common fund orders in class actions are legal and not unconstitutional, six judges found Friday after a history-making joint sitting of two appeals courts.